|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07D 215/56 | |
| A61K 31/4704 | |||
| A61P 11/00 |
| (11) | Patento numeris | 3204358 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 15849070.6 |
| Europos patento paraiškos padavimo data | 2015-10-07 | |
| (97) | Europos patento paraiškos paskelbimo data | 2017-08-16 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2018-09-19 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2015/054577 |
| Data | 2015-10-07 |
| (87) | Numeris | WO 2016/057730 |
| Data | 2016-04-14 |
| (30) | Numeris | Data | Šalis |
| 201462060828 P | 2014-10-07 | US |
| (72) |
STROHMEIER, Mark, US
CAESAR, JR., John P., US
CONNELLY, Patrick Raymond, US
FAWAZ, Majed, US
LUSS-LUSIS, Eduard, US
MCCLAIN, Brian R., US
MEDEK, Ales, US
MIAO, Hai, US
NTI-ADDAE, Kwame Wiredu, US
YIN, Ping, US
ZHANG, Yuegang, US
|
| (73) |
Vertex Pharmaceuticals Incorporated,
50 Northern Avenue, Boston, MA 02210,
US
|
| (54) | CO-CRYSTALS OF MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR |
| CO-CRYSTALS OF MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR |